Our reporters are on the ground at the BIO International Convention in San Diego, bringing you all the news and must-see highlights. The 2022 BIO International Convention is back in person for the first time in three years.
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said Auriane …
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
Nucleic acid and gene therapies are the future of medicine. However, current delivery methods pose many limitations when it comes to getting potential therapies where …
Two years into a global pandemic that disproportionately affected Black and Brown communities, executives are seeking to ignite change in the biotechnology ecosystem. During the …
Breaking the system to make a change: How biotech leaders drive diversity and inclusion Read More »
It’s an exciting time for research into microbiome therapeutics. This can be seen in the explosion of new clinical studies in the field, which, as …
A gut check on microbiome therapeutics development Read More »
Nearly 16 million Americans are taking care of someone with Alzheimer’s disease – and the cost of caring for someone with the disease goes far …
Tackling Alzheimer’s requires cooperation, access, and broad and equitable coverage Read More »
There are more barriers between patients and the medications that they need than price, agreed experts at the BIO International Convention in June 2022. “This …
How to overcome non-price barriers to patient access to medical care, drugs Read More »
More than two years on from COVID, offices and the world of work remain forever changed. Many companies are offering hybrid work models, where employees …
How biotech recruiting has changed in the post-COVID world Read More »
The journey of the data point is no longer linear, as advanced digital innovations are now employed throughout all the phases of drug development, agreed …
The data point is no longer linear, say data scientists Read More »
Thanks to gene therapies, previously untreatable diseases are now treatable and patient quality of life has improved exponentially. Yet, gene therapy regulatory challenges, along with …
How gene therapy regulatory challenges impact R&D, manufacturing, patients Read More »
John Trizzino, Executive Vice President, Chief Commercial Officer, and Chief Business Officer of Novavax, joined Good Day BIO Live at the BIO International Convention, where …
Vaccine in 100 days ‘extraordinarily possible’ says John Trizzino of Novavax Read More »
Misinformation. Not COVID. Not heart disease. Not cancer. Misinformation. That’s what the Commissioner of the U.S. Food and Drug Administration recently declared the leading cause …
BIO Board Member: Biotech’s voice needs to get louder – and clearer Read More »
